125 related articles for article (PubMed ID: 34493196)
21. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
22. Malignancy in Systemic Lupus Erythematosus (SLE) Patients.
Cader RA; Mei Yee AK; Yassin A; Ahmad I; Haron SN
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3551-3555. PubMed ID: 30583682
[TBL] [Abstract][Full Text] [Related]
23. [Clinical Features and Risk Factors of Systemic Lupus Erythematosus Complicated with Cytomegalovirus Infection].
Tan YT; Shi XC; Liu XQ; Zeng XF; Zhou BT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):749-754. PubMed ID: 33423721
[TBL] [Abstract][Full Text] [Related]
24. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.
Pastore DEA; Costa ML; Surita FG
Lupus; 2019 Oct; 28(12):1417-1426. PubMed ID: 31551036
[TBL] [Abstract][Full Text] [Related]
25. Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?
Rascu A; Manger K; Kraetsch HG; Kalden JR; Manger B
Lupus; 1996 Aug; 5(4):323-7. PubMed ID: 8869906
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center.
El Hadidi KT; Medhat BM; Abdel Baki NM; Abdel Kafy H; Abdelrahaman W; Yousri AY; Attia DH; Eissa M; El Dessouki D; Elgazzar I; Elgengehy FT; El Ghobashy N; El Hadary H; El Mardenly G; El Naggar H; El Nahas AM; El Refai RM; El Rwiny HA; Elsman RM; Galal M; Ghoniem S; Maged LA; Sally SM; Naji H; Saad S; Shaaban M; Sharaf M; Sobhy N; Soliman RM; El Hadidi TS
Lupus; 2018 May; 27(6):1030-1038. PubMed ID: 29431056
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus.
Kapoor T; Mahadeshwar P; Hui-Yuen J; Quinnies K; Tatonetti N; Gartshteyn Y; Guo C; Geraldino-Pardilla L; Askanase AD
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32513809
[TBL] [Abstract][Full Text] [Related]
29. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
[TBL] [Abstract][Full Text] [Related]
30. Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course.
Ersin M; Demirel M; Ekinci M; Mert L; Çetin Ç; Artım Esen B; İnanç M; Kılıçoğlu ÖI
Lupus; 2021 Sep; 30(10):1603-1608. PubMed ID: 34259056
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with active tuberculosis in Colombian patients with systemic lupus erythematosus: a case-control study.
González-Naranjo LA; Coral-Enríquez JA; Restrepo-Escobar M; Muñoz-Vahos CH; Jaramillo-Arroyave D; Vanegas-García AL; Eraso R; Vásquez G; Jaimes F
Clin Rheumatol; 2021 Jan; 40(1):181-191. PubMed ID: 32529420
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology and risk factors associated with avascular necrosis in patients with autoimmune diseases: a nationwide study.
Tsai HL; Chang JW; Lu JH; Liu CS
Korean J Intern Med; 2022 Jul; 37(4):864-876. PubMed ID: 35236014
[TBL] [Abstract][Full Text] [Related]
33. Damage in systemic lupus erythematosus and its association with corticosteroids.
Zonana-Nacach A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
[TBL] [Abstract][Full Text] [Related]
34. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
Akawatcharangura P; Taechakraichana N; Osiri M
Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?
Mok MY; Farewell VT; Isenberg DA
Ann Rheum Dis; 2000 Jun; 59(6):462-7. PubMed ID: 10834864
[TBL] [Abstract][Full Text] [Related]
37. Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience.
Mahmoud GA; Shahin AA; Zayed HS; Moghazy A; Eissa BM
Lupus; 2018 Aug; 27(9):1562-1569. PubMed ID: 29788810
[TBL] [Abstract][Full Text] [Related]
38. [Long-term analysis of clinical disease activity and chronic organ damage in patients with systemic lupus erythematosus].
Rapp CA; Berner B; Müller GA; Reuss-Borst MA
Z Rheumatol; 2002 Oct; 61(5):521-31. PubMed ID: 12399879
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients.
Kunyakham W; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R
Asian Pac J Allergy Immunol; 2012 Jun; 30(2):152-7. PubMed ID: 22830295
[TBL] [Abstract][Full Text] [Related]
40. An analysis of joint replacement in patients with systemic lupus erythematosus.
Mourão AF; Amaral M; Caetano-Lopes J; Isenberg D
Lupus; 2009 Dec; 18(14):1298-302. PubMed ID: 19850657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
